sccl

SCCL is a biosciences company that develops and produces innovative products from dairy cow colostrum. Scientists at SCCL have developed methods of accurately measuring key immunological, metabolic and nutritional components found in colostrum.

They produce natural, spray-dried colostrum via their proprietary processing method to preserve the levels of key components. This natural colostrum maintains the specific levels of important elements designed to assure optimal immune function immunity against and provide key growth and metabolic factors to optimize bovine calf care and development.

Buying excess colostrum from 5000+ dairy farmers across North America (Canada, USA, Mexico) and a growing supply in Europe (Scotland), the SCCL supply chain supports the dairy economy by turning waste into revenue.

The SCCL processes assure that all-natural, safe, stable, efficacious colostrum can be available to dairy and beef producers at the time of calving. Producers intent on achieving the genetic potential they have invested in, understand that optimizing inputs allows for optimized output.

SCCL aims to be the global leader in the creation, production and application of all-natural veterinary biological grade colostrum products and protocols. These products include HEADSTART, Calf’s Choice Total, Colostro Bovino Completo, Colostrum Po, Colostrum 200 and many private label presentations.

Mission Statement

Providing optimum colostrum protocols and applications: more about educating and demonstrating effective applications.

Gregg Topoleski serves as Chief Financial Officer for URUS. With over 23 years in Finance, he has developed a deep operational and strategic skillset that will complement the URUS leadership team. Before joining URUS, most recently, Gregg served as a Finance Executive for Exact Sciences and 3M/KCI. He started his career with GE in the Healthcare and Industrial Technologies divisions.

Petra Vijverberg is Chief Integration Officer of URUS. She brings with her experience as Managing Director Volkswagen and Sr Vice President of Strategy & Business Development of the PON group. At URUS she leads the coordination, alignment, and innovation of People Development & HR, IT, Digital Strategy, Marketing & Global Development, Corporate Development, and Supply Chain & Logistics.

Kevin Muxlow is Chief Operating Officer for URUS. He has a leadership focus on A.I. sales channels, SCCL, and VAS businesses while also building culture and strategy and supporting growth across the URUS Group. Kevin started with the company in 2005 in marketing, people development, and sales leadership roles.

Paul Hunt is the Chief Executive Officer of URUS. He took on this role after serving as the COO of URUS, where he provided leadership and support to GENEX, PEAK, and the URUS aspects of Corporate Development, People Development, and Distribution. Prior to the creation of URUS, Paul was the Alta Genetics COO since 2004. Paul has spent his entire career within URUS and its predecessors.